Dow Inc. Swings to Loss Amidst Soaring Restructuring Costs

Ticker: DOW · Form: 10-Q · Filed: 2025-10-24T00:00:00.000Z

Sentiment: bearish

Topics: Chemicals, Restructuring, Net Loss, Sales Decline, Cash Flow, Earnings Per Share, Manufacturing

Related Tickers: DOW, DD, CTVA

TL;DR

**Dow's Q3 is a disaster, with massive restructuring charges wiping out profits; sell now before it gets worse.**

AI Summary

DOW INC. reported a significant decline in net income for the nine months ended September 30, 2025, posting a net loss of $967 million, a sharp contrast to the net income of $1,236 million in the same period of 2024. This downturn was primarily driven by a substantial increase in restructuring and asset related charges, which surged to $822 million in 2025 from $69 million in 2024. Net sales also decreased, falling to $30,508 million for the nine-month period in 2025 from $32,559 million in 2024, representing a 6.3% reduction. Despite the net loss, the company's cash and cash equivalents significantly increased to $4,609 million as of September 30, 2025, from $2,189 million at December 31, 2024, largely due to $2,941 million in cash provided by financing activities, including proceeds from the sale of noncontrolling interests. Capital expenditures decreased to $1,911 million in 2025 from $2,173 million in 2024, indicating a reduction in investment. The company also saw a decrease in earnings per common share, moving from $1.65 in 2024 to a loss of $1.53 in 2025.

Why It Matters

This filing reveals a challenging period for Dow Inc., marked by a significant net loss and declining sales, which could signal broader economic headwinds impacting the chemicals sector. The substantial increase in restructuring charges suggests the company is undergoing significant operational changes, potentially impacting employee numbers and facility operations. For investors, the shift from profit to a $967 million loss and a negative EPS of $1.53 is a major red flag, despite the strong cash position. Competitors might see this as an opportunity to gain market share, while customers could face price adjustments or supply chain shifts as Dow Inc. navigates its restructuring efforts.

Risk Assessment

Risk Level: high — The risk level is high due to the significant net loss of $967 million for the nine months ended September 30, 2025, compared to a net income of $1,236 million in the prior year. This is exacerbated by a massive increase in 'Restructuring and asset related charges - net' to $822 million in 2025 from $69 million in 2024, indicating substantial operational challenges and potential future write-downs.

Analyst Insight

Investors should consider reducing their exposure to DOW given the substantial net loss and the significant increase in restructuring charges. Monitor future filings closely for signs of stabilization in sales and a reduction in these one-time charges, as the current trend suggests ongoing operational difficulties.

Financial Highlights

revenue
$30,508M
net Income
$(967)M
eps
$(1.53)
cash Position
$4,609M
revenue Growth
-6.3%

Revenue Breakdown

SegmentRevenueGrowth
Net Sales$30,508M-6.3%

Key Numbers

Key Players & Entities

FAQ

Why did Dow Inc. report a net loss in Q3 2025?

Dow Inc. reported a net loss of $967 million for the nine months ended September 30, 2025, primarily due to a substantial increase in 'Restructuring and asset related charges - net' which surged to $822 million, up from $69 million in the same period of 2024.

How did Dow Inc.'s net sales perform in the latest quarter?

Dow Inc.'s net sales decreased to $30,508 million for the nine months ended September 30, 2025, down from $32,559 million in the prior year, representing a 6.3% decline.

What was the impact of restructuring on Dow Inc.'s financials?

Restructuring and asset related charges had a significant negative impact, increasing to $822 million for the nine months ended September 30, 2025, from $69 million in the same period of 2024, directly contributing to the company's net loss.

What is Dow Inc.'s cash position as of September 30, 2025?

As of September 30, 2025, Dow Inc. reported cash and cash equivalents of $4,609 million, a significant increase from $2,189 million at December 31, 2024, largely bolstered by financing activities.

How did Dow Inc.'s earnings per share change year-over-year?

Dow Inc.'s diluted earnings per common share shifted from a positive $1.65 for the nine months ended September 30, 2024, to a loss of $1.53 for the same period in 2025.

What were Dow Inc.'s capital expenditures for the nine months ended September 30, 2025?

Capital expenditures for Dow Inc. were $1,911 million for the nine months ended September 30, 2025, a decrease from $2,173 million in the corresponding period of 2024.

What is the outlook for Dow Inc. given these results?

The significant net loss and increased restructuring charges suggest a challenging outlook for Dow Inc. in the near term, as the company navigates operational changes and market pressures. Investors should monitor for signs of successful restructuring and improved sales performance.

How do the current results compare to Dow Inc.'s previous performance?

The current results represent a substantial downturn compared to the previous year, with a net loss of $967 million in 2025 versus a net income of $1,236 million in 2024, and a 6.3% decrease in net sales.

What are the main risks highlighted in Dow Inc.'s 10-Q filing?

The filing highlights risks such as ongoing conflicts in Russia/Ukraine and the Middle East, fluctuations in energy and raw material prices, increased concerns about plastics in the environment, and global economic conditions like inflation and interest rates, all of which could impact future results.

Did Dow Inc. issue any new debt or equity in the last nine months?

Yes, Dow Inc. reported proceeds from the issuance of long-term debt totaling $2,652 million and proceeds from the sale of noncontrolling interests amounting to $2,943 million for the nine months ended September 30, 2025.

Risk Factors

Industry Context

The chemical industry is cyclical and sensitive to global economic conditions, impacting demand and pricing for Dow's products. Competitors face similar pressures from fluctuating raw material costs and evolving sustainability regulations. Recent trends indicate a focus on specialty chemicals and sustainable solutions, though macroeconomic headwinds are currently dampening overall growth.

Regulatory Implications

Dow operates in a highly regulated industry, facing compliance requirements related to environmental protection, product safety, and chemical manufacturing. Changes in international trade policies and tariffs could also impact its global supply chain and profitability.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Glossary

Restructuring and asset related charges
Costs incurred by a company related to significant reorganizations, shutdowns, or disposals of assets. These can include severance payments, asset write-downs, and closure costs. (A massive increase in these charges to $822 million in 2025 was the primary reason for Dow's net loss, highlighting significant operational adjustments or impairments.)
Noncontrolling interests
The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership stake of outside shareholders in a consolidated subsidiary. (Proceeds from the sale of noncontrolling interests contributed significantly to cash from financing activities, bolstering the company's cash position despite operational losses.)
Diluted EPS
Earnings per share calculated by dividing net income by the total number of diluted shares outstanding. Diluted shares include common stock equivalents like stock options and convertible securities. (Dow's diluted EPS turned negative at $(1.53) for the nine months ended September 30, 2025, down from $1.65 in the prior year, reflecting the company's shift to a net loss.)
Capital expenditures
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, buildings, and equipment. These are investments in the company's long-term operational capacity. (A decrease in capital expenditures to $1,911 million from $2,173 million suggests a potential slowdown in investment or a focus on cost containment.)

Year-Over-Year Comparison

Dow Inc. has experienced a significant downturn compared to the prior year's nine-month period. Net sales have decreased by 6.3% to $30,508 million, and profitability has sharply deteriorated, resulting in a net loss of $967 million compared to a net income of $1,236 million. This swing is largely attributable to a massive increase in restructuring and asset related charges, which rose from $69 million to $822 million. While cash reserves have strengthened due to financing activities, operational performance has weakened considerably, reflected in the negative diluted EPS of $(1.53) versus $1.65 previously.

Filing Stats: 4,850 words · 19 min read · ~16 pages · Grade level 17.4 · Accepted 2025-10-24 07:49:00

Key Financial Figures

Filing Documents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements . 5 Dow Inc. and Subsidiaries: Consolidated Statements of Income . 5 Consolidated Statements of Comprehensive Income . 6 Consolidated Balance Sheets . 7 Consolidated Statements of Cash Flows . 8 Consolidated Statements of Equity . 9 The Dow Chemical Company and Subsidiaries: Consolidated Statements of Income . 10 Consolidated Statements of Comprehensive Income . 11 Consolidated Balance Sheets . 12 Consolidated Statements of Cash Flows . 13 Consolidated Statements of Equity . 14 Dow Inc. and Subsidiaries and The Dow Chemical Company and Subsidiaries: Notes to the Consolidated Financial Statements . 15 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations . 45 Results of Operations . 48 Changes in Financial Condition . 55 Other Matters . 62 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk . 63 Item 4.

Controls and Procedures

Controls and Procedures . 63

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1. Legal Proceedings . 64 Item 1A. Risk Factors . 65 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds . 66 Item 4. Mine Safety Disclosures . 66 Item 5. Other Information . 66 Item 6. Exhibits . 67 SIGNATURE 68 3 Table of Contents Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company. CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS Certain statements in this report are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases. Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Dow Inc. and Subsidiaries Consolidated Statements of Income Three Months Ended Nine Months Ended In millions, except per share amounts (Unaudited) Sep 30, 2025 Sep 30, 2024 Sep 30, 2025 Sep 30, 2024 Net sales $ 9,973 $ 10,879 $ 30,508 $ 32,559 Cost of sales 9,242 9,809 28,523 28,888 Research and development expenses 191 208 579 608 Selling, general and administrative expenses 340 396 1,053 1,228 Amortization of intangibles 46 76 185 234 Restructuring and asset related charges - net 23 24 822 69 Equity in earnings (losses) of nonconsolidated affiliates ( 72 ) 2 ( 122 ) 45 Sundry income (expense) - net 185 119 345 256 Interest income 47 36 114 143 Interest expense and amortization of debt discount 221 199 646 595 Income (loss) before income taxes 70 324 ( 963 ) 1,381 Provision (credit) for income taxes ( 54 ) 84 4 145 Net income (loss) 124 240 ( 967 ) 1,236 Net income attributable to noncontrolling interests 62 26 113 67 Net income (loss) available for Dow Inc. common stockholders $ 62 $ 214 $ ( 1,080 ) $ 1,169 Per common share data: Earnings (loss) per common share - basic $ 0.08 $ 0.30 $ ( 1.53 ) $ 1.65 Earnings (loss) per common share - diluted $ 0.08 $ 0.30 $ ( 1.53 ) $ 1.65 Weighted-average common shares outstanding - basic 711.8 702.3 709.4 703.5 Weighted-average common shares outstanding - diluted 713.2 703.6 709.4 704.9 Depreciation $ 536 $ 501 $ 1,586 $ 1,470 Capital expenditures $ 564 $ 736 $ 1,911 $ 2,173 See Notes to the Consolidated Financial Statements. 5 Table of Contents Dow Inc. and Subsidiaries Consolidated Statements of Comprehensive Income Three Months Ended Nine Months Ended In millions (Unaudited) Sep 30, 2025 Sep 30, 2024 Sep 30, 2025 Sep 30, 2024 Net income (loss) $ 124 $ 240 $ ( 967 ) $ 1,236 Other comprehensive income (loss), net of tax Unrealized gains on investments 57 34 67 89 Cumulative translation adjustments ( 33 ) 199 218 34 Pension and other postretirement be

View on Read The Filing